Sculptor Capital LP Buys Shares of 430,838 Novanta Inc. $NOVT

Sculptor Capital LP acquired a new stake in Novanta Inc. (NASDAQ:NOVT) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 430,838 shares of the technology company’s stock, valued at approximately $51,265,000. Sculptor Capital LP owned approximately 1.20% of Novanta at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Assetmark Inc. boosted its holdings in shares of Novanta by 22.4% in the fourth quarter. Assetmark Inc. now owns 541 shares of the technology company’s stock valued at $64,000 after acquiring an additional 99 shares in the last quarter. EverSource Wealth Advisors LLC lifted its stake in Novanta by 120.1% during the fourth quarter. EverSource Wealth Advisors LLC now owns 427 shares of the technology company’s stock valued at $51,000 after purchasing an additional 233 shares during the last quarter. Van ECK Associates Corp lifted its stake in Novanta by 17.2% during the third quarter. Van ECK Associates Corp now owns 1,627 shares of the technology company’s stock valued at $163,000 after purchasing an additional 239 shares during the last quarter. Amundi lifted its stake in Novanta by 1.4% during the third quarter. Amundi now owns 18,287 shares of the technology company’s stock valued at $1,908,000 after purchasing an additional 245 shares during the last quarter. Finally, Nicolet Advisory Services LLC lifted its stake in Novanta by 7.1% during the third quarter. Nicolet Advisory Services LLC now owns 4,046 shares of the technology company’s stock valued at $409,000 after purchasing an additional 269 shares during the last quarter. 98.35% of the stock is currently owned by institutional investors.

Novanta Stock Down 2.4%

NOVT stock opened at $156.63 on Tuesday. Novanta Inc. has a 52-week low of $98.27 and a 52-week high of $171.85. The company’s 50 day simple moving average is $143.90 and its 200-day simple moving average is $133.17. The company has a debt-to-equity ratio of 0.15, a current ratio of 3.56 and a quick ratio of 2.69. The firm has a market capitalization of $5.58 billion, a P/E ratio of 113.50 and a beta of 1.67.

Novanta (NASDAQ:NOVT) last released its quarterly earnings results on Monday, May 11th. The technology company reported $0.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.78 by $0.03. Novanta had a net margin of 5.35% and a return on equity of 12.06%. The business had revenue of $257.71 million for the quarter, compared to analyst estimates of $253.40 million. During the same quarter in the previous year, the business earned $0.74 earnings per share. The firm’s revenue was up 10.4% compared to the same quarter last year. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q2 2026 guidance at 0.810-0.860 EPS. As a group, equities research analysts anticipate that Novanta Inc. will post 3.59 EPS for the current year.

Analysts Set New Price Targets

NOVT has been the subject of several recent research reports. Wall Street Zen lowered shares of Novanta from a “buy” rating to a “hold” rating in a research note on Saturday, April 18th. Robert W. Baird set a $180.00 target price on shares of Novanta in a research note on Tuesday, June 9th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Novanta in a research note on Friday, April 17th. One analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $180.00.

Insiders Place Their Bets

In other Novanta news, CEO Matthijs Glastra sold 7,500 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $150.43, for a total value of $1,128,225.00. Following the transaction, the chief executive officer owned 42,761 shares in the company, valued at approximately $6,432,537.23. This represents a 14.92% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 1.20% of the company’s stock.

About Novanta

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.